← Back to Clinical Trials
Recruiting NCT07660965

NCT07660965 The Effect of Podcast Breastfeeding Training on Mothers of Preterm Infants

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07660965
Status Recruiting
Phase
Sponsor Dilek Kucuk Alemdar
Condition Breastfeeding
Study Type INTERVENTIONAL
Enrollment 56 participants
Start Date 2025-07-20
Primary Completion 2026-06-15

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Breastfeeding education via podcast

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 56 participants in total. It began in 2025-07-20 with a primary completion date of 2026-06-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to examine the effect of breastfeeding education provided via podcast to mothers of preterm infants admitted to the neonatal intensive care unit on the mothers' breastfeeding success, awareness, motivation, self-efficacy, and perception of insufficient milk supply. The research aims to help mothers overcome challenges in the breastfeeding process by increasing their knowledge levels and to strengthen their confidence in this process. Thus, the goal is to better meet the nutritional needs of preterm infants and to improve mothers' breastfeeding experiences in a positive direction.

Eligibility Criteria

Inclusion Criteria: * The mother must volunteer to participate in the study, * The mother must be 18 years of age or older * After being accepted into the study, the mother must express her intention to breastfeed her baby * The mother must be able to speak and read Turkish * The mother's baby being between 32 and 37 weeks gestation Exclusion Criteria: * Illegal drug and tobacco use by the mother * The mother's use of alcohol during pregnancy and after childbirth * Active tuberculosis in the mother * The presence of Herpes simplex virus lesions on the mother's breast * The presence of a maternal psychiatric disorder * Having prior experience breastfeeding a preterm infant * Having a condition that prevents breastfeeding * Mothers who have had multiple births.

Contact & Investigator

Central Contact

Dilek Küçük Alemdar, Professor

✉ dilekkucukalemdar@gmail.com

📞 +905468435840

Frequently Asked Questions

Who can join the NCT07660965 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Breastfeeding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07660965 currently recruiting?

Yes, NCT07660965 is actively recruiting participants. Contact the research team at dilekkucukalemdar@gmail.com for enrollment information.

Where is the NCT07660965 trial being conducted?

This trial is being conducted at Merkez, Turkey (Türkiye).

Who is sponsoring the NCT07660965 clinical trial?

NCT07660965 is sponsored by Dilek Kucuk Alemdar. The trial plans to enroll 56 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology